This inventor holds 1 USPTO granted patent. Top assignee: Adlai Nortye Biopharma Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Meng Lv: Innovator in Immune-Related Disorders
Introduction
Meng Lv is a prominent inventor based in Zhejiang, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target immune-related disorders. His innovative work has led to the creation of a patent that showcases his expertise and dedication to advancing medical science.
Latest Patents
Meng Lv holds a patent for a PD-L1 antagonist compound. This patent includes a compound of Formula (I) and a pharmaceutical composition thereof. The method described in the patent is aimed at preventing and/or treating immune-related disorders, highlighting the potential impact of his work on healthcare.
Career Highlights
Meng Lv is associated with Adlai Nortye Biopharma Co., Ltd., where he continues to push the boundaries of pharmaceutical research. His role in the company allows him to collaborate with other talented professionals in the field, further enhancing the development of innovative treatments.
Collaborations
Some of his notable coworkers include Zhiyong Yu and Pan Li. Their collective efforts contribute to the advancement of research and the development of new therapeutic solutions.
Conclusion
Meng Lv's contributions to the field of pharmaceuticals, particularly through his patent for a PD-L1 antagonist compound, demonstrate his commitment to addressing immune-related disorders. His work at Adlai Nortye Biopharma Co., Ltd. and collaborations with esteemed colleagues further solidify his position as a key innovator in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile